Periphagen

Biopharmaceutical company developing HSV-1 vectors for gene therapy and neurologic diseases

placePittsburgh, Pennsylvania, United States calendar_todayFounded 2012 groups2 employees language periphagen.com

Registered entities

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon